Science Explorer Back to mapMap
Discussion
Company · Seattle · United States

Insilicos (United States)

Research works
56
▲ 144% vs 2018-21
Citations
1.4k
24.2 per fractional work
Top-10% rate
22.9%
all institutions 10.0%
Open access
63%
world 40%
International
52%
world 18%

Not ranked overall: Insilicos (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Insilicos (United States) work in?

In 2022-now, 48% of research at Insilicos (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (24%), Computer Science (15%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 16 fractional works · 48.2% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 44.2% of its workMolecular Biology: 12 fractional works · 37.0% of its workGenetics: 1 fractional works · 2.1% of its workCell Biology: 0 fractional works · 1.5% of its workAging: 0 fractional works · 1.5% of its workCancer Research: 0 fractional works · 1.0% of its workBiophysics: 0 fractional works · 0.8% of its workBiochemistry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 2.3% of its workImmunology: 1 fractional works · 2.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.8% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workHealth Sciences: 8 fractional works · 25.3% of its workMedicine: 8 fractional works · 24.5% of its workPulmonary and Respiratory Medicine: 3 fractional works · 10.1% of its workOncology: 2 fractional works · 5.7% of its workPhysiology: 1 fractional works · 1.6% of its workReproductive Medicine: 0 fractional works · 1.2% of its workComplementary and alternative medicine: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.5% of its workSmall Animals: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.3% of its workPhysical Sciences: 8 fractional works · 25.2% of its workComputer Science: 5 fractional works · 14.7% of its workComputational Theory and Mathematics: 3 fractional works · 9.5% of its workArtificial Intelligence: 2 fractional works · 5.2% of its workMaterials Science: 2 fractional works · 4.7% of its workMaterials Chemistry: 2 fractional works · 4.7% of its workEngineering: 1 fractional works · 2.7% of its workBiomedical Engineering: 1 fractional works · 1.7% of its workOcean Engineering: 0 fractional works · 0.5% of its workMechanical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 0.7% of its workInorganic Chemistry: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 1.2% of its workDecision Sciences: 0 fractional works · 0.8% of its workInformation Systems and Management: 0 fractional works · 0.8% of its workPsychology: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKInsilicos (UnitedStates)32fractional works, 2022-now
Life Sciences48%Physical Sciences25%Health Sciences25%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1444.2%
    2. Immunology and Microbiology12.3%
    3. Pharmacology, Toxicology and Pharmaceutics01.0%
    4. Agricultural and Biological Sciences00.5%
    5. Neuroscience00.3%
    1. Medicine824.5%
    2. Veterinary00.5%
    3. Health Professions00.3%
    1. Computer Science514.7%
    2. Materials Science24.7%
    3. Engineering12.7%
    4. Chemistry12.2%
    5. Environmental Science01.0%
    1. Decision Sciences00.8%
    2. Psychology00.3%
    3. Social Sciences00.1%
    4. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.29× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 2.25× its world share, 1 worksImmunology and Micro…Neuroscience: 0.17× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.77× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.40× its world share, 1 worksChemistryComputer Science: 1.89× its world share, 5 worksComputer ScienceEngineering: 0.18× its world share, 1 worksEngineeringEnvironmental Science: 0.19× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.36× its world share, 2 worksMaterials ScienceHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 1.27× its world share, 8 worksMedicineVeterinary: 3.36× its world share, 0 worksVeterinaryDecision Sciences: 0.82× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…Psychology: 0.09× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.29×14 works
  2. Veterinary3.36×0 works
  3. Pharmacology, Toxicology and Pharmaceutics2.77×0 works
  4. Immunology and Microbiology2.25×1 works
  5. Computer Science1.89×5 works
  6. Chemistry1.40×1 works
  7. Materials Science1.36×2 works
  8. Medicine1.27×8 works
  9. Decision Sciences0.82×0 works
  10. Environmental Science0.19×0 works
  11. Engineering0.18×1 works
  12. Neuroscience0.17×0 works
  13. Health Professions0.13×0 works
  14. Agricultural and Biological Sciences0.11×0 works
  15. Psychology0.09×0 works
  16. Economics, Econometrics and Finance0.02×0 works
  17. Social Sciences0.01×0 works

Who are the top researchers at Insilicos (United States)?

Ranked on the quality score, Alex A. Zhavoronkov, Alex Aliper and Daniil A. Polykovskiy lead among researchers whose main affiliation is Insilicos (United States).

  1. 1 Alex A. Zhavoronkov United States · #26,294 worldwide 20k citations · 446 works
  2. 2 Alex Aliper United States · #57,950 worldwide 5.7k citations · 101 works
  3. 3 Daniil A. Polykovskiy United States · #152,254 worldwide 4k citations · 35 works
  4. 4 Quentin Vanhaelen United States · #239,707 worldwide 2.7k citations · 42 works
  5. 5 Franco Cortese United States · #362,936 worldwide 960 citations · 24 works
  6. 6 Maksim Kuznetsov United States · #1,380,319 worldwide 1.8k citations · 17 works
  7. 7 Rim Shayakhmetov United States · #2,522,550 worldwide 358 citations · 19 works
All ranked researchers at Insilicos (United States)

What are the most cited papers from Insilicos (United States)?

The most cited paper from Insilicos (United States) is "A cross-platform toolkit for mass spectrometry and proteomics" (Matthew Chambers et al., 2012), with 4,457 citations. Next come "mzML—a Community Standard for Mass Spectrometry Data" (804) and "A guided tour of the Trans‐Proteomic Pipeline" (793).

Most cited papers
#PaperReleasedCitations
1 A cross-platform toolkit for mass spectrometry and proteomics Matthew Chambers et al. · Nature Biotechnology Open access Oct 2012 4,457
2 mzML—a Community Standard for Mass Spectrometry Data Lennart Martens, Matthew Chambers, Marc Sturm et al. · Molecular & Cellular Proteomics Open access 17 Aug 2010 804
3 A guided tour of the Trans‐Proteomic Pipeline Eric W. Deutsch, Luis Mendoza, David D. Shteynberg et al. · PROTEOMICS Open access 25 Jan 2010 793
4 Reinforced Adversarial Neural Computer for de Novo Molecular Design Eugene Lane, Arip Asadulaev, Yan A. Ivanenkov et al. · Journal of Chemical Information and Modeling Open access 15 May 2018 397
5 A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models Feng Ren et al. · Nature Biotechnology Open access 8 Mar 2024 327
All 58 most cited papers, with filters and sorting

Which keywords describe research at Insilicos (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Machine Learning, Cancer Therapy, Medicinal Chemistry, Molecular Docking, Virtual Screening, Transcriptional Regulation, Molecular Dynamics and Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Machine Learning5▲ 4.7×8 topics
  2. Cancer Therapy4▲ 20×9 topics
  3. Medicinal Chemistry3▲ 39×4 topics
  4. Molecular Docking3▲ 77×1 topic
  5. Virtual Screening3▲ 104×1 topic
  6. Cancer2▲ 5.1×12 topics
  7. Transcriptional Regulation2▲ 40×4 topics
  8. Molecular Dynamics2▲ 34×2 topics
  9. Fibrosis2▲ 24×4 topics
  10. High-Throughput1▲ 71×1 topic
  11. Materials Informatics1▲ 71×1 topic
  12. Epithelial-Mesenchymal Transition1▲ 40×2 topics
  13. Gene Expression1▲ 6.5×6 topics
  14. Bioinformatics1▲ 32×3 topics
  15. Cell Proliferation1▲ 43×4 topics
  16. Epigenetic Regulation1▲ 17×3 topics
  17. Idiopathic Pulmonary Fibrosis1▲ 76×1 topic
  18. Interstitial Lung Disease1▲ 55×1 topic
  19. Tumor Microenvironment1▲ 7.9×4 topics
  20. Data Integration1▲ 20×2 topics
  21. Genomics1▲ 12×2 topics
  22. Oxidative Stress1▲ 2.0×7 topics
  23. Biomedical Ontologies1▲ 118×1 topic
  24. Deep Learning1◆ 0.93×3 topics
  25. Oncogenic Mutations1▲ 112×2 topics
  26. Text Mining1▲ 23×1 topic

Which research topics does Insilicos (United States) publish most on?

By volume in 2022-now: Computational Drug Discovery Methods, Machine Learning in Materials Science, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Biomedical Text Mining and Ontologies.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
  2. 2 Machine Learning in Materials Science Materials Chemistry 1 works
  3. 3 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  4. 4 Biomedical Text Mining and Ontologies Molecular Biology 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 1 works
  6. 6 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 1 works
  7. 7 Advanced Graph Neural Networks Artificial Intelligence 1 works
  8. 8 Topic Modeling Artificial Intelligence 1 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  10. 10 Protein Structure and Dynamics Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.9%not open37.1%

World: 40% of research is openly available.

with international co-authors51.7%domestic only48.3%

World: 18% is written across borders.

How has Insilicos (United States)'s research output changed?

Output in 2022-2025 was 144% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Insilicos (United States) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00010%0.00020%Insilicos (United States)0.00017% in 2025200020102020

Fractional works of Insilicos (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Insilicos (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.